HomeCompareMEDIF vs EPRT

MEDIF vs EPRT: Dividend Comparison 2026

MEDIF yields 4345.46% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDIF wins by $15969693446288.73M in total portfolio value
10 years
MEDIF
MEDIF
● Live price
4345.46%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15969693446288.79M
Annual income
$15,278,069,441,942,714,000.00
Full MEDIF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — MEDIF vs EPRT

📍 MEDIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDIFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDIF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEDIF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDIF
Annual income on $10K today (after 15% tax)
$369,364.48/yr
After 10yr DRIP, annual income (after tax)
$12,986,359,025,651,306,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, MEDIF beats the other by $12,986,359,025,651,296,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDIF + EPRT for your $10,000?

MEDIF: 50%EPRT: 50%
100% EPRT50/50100% MEDIF
Portfolio after 10yr
$7984846723144.43M
Annual income
$7,639,034,720,971,363,000.00/yr
Blended yield
95.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

MEDIF
No analyst data
Altman Z
-2.9
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDIF buys
0
EPRT buys
0
No recent congressional trades found for MEDIF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDIFEPRT
Forward yield4345.46%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$15969693446288.79M$63.4K
Annual income after 10y$15,278,069,441,942,714,000.00$12,840.73
Total dividends collected$15922667488789.34M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MEDIF vs EPRT ($10,000, DRIP)

YearMEDIF PortfolioMEDIF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$445,246$434,546.44$11,205$505.18+$434.0KMEDIF
2$18,558,681$18,082,267.04$12,672$682.46+$18.55MMEDIF
3$724,251,944$704,394,155.22$14,490$930.48+$724.24MMEDIF
4$26,465,566,588$25,690,617,008.13$16,786$1,282.69+$26465.55MMEDIF
5$905,687,152,836$877,368,996,586.58$19,753$1,791.56+$905687.13MMEDIF
6$29,029,592,495,582$28,060,507,242,048.22$23,677$2,541.64+$29029592.47MMEDIF
7$871,632,797,918,927$840,571,133,948,653.80$29,008$3,672.99+$871632797.89MMEDIF
8$24,520,223,407,609,444$23,587,576,313,836,190.00$36,463$5,425.08+$24520223407.57MMEDIF
9$646,377,574,155,211,500$620,140,935,109,069,400.00$47,238$8,221.57+$646377574155.16MMEDIF
10$15,969,693,446,288,792,000$15,278,069,441,942,714,000.00$63,385$12,840.73+$15969693446288.73MMEDIF

MEDIF vs EPRT: Complete Analysis 2026

MEDIFStock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Full MEDIF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this MEDIF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDIF vs SCHDMEDIF vs JEPIMEDIF vs OMEDIF vs KOMEDIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.